Trademark: 97213458
Word
7
Status Date
Thursday, January 4, 2024
Filing Date
Tuesday, January 11, 2022
Published for Opposition
Tuesday, November 29, 2022
5 Pharmaceutical preparations and substances for the treatment of diseases, namely, genetic diseases, diseases of the immune system, infectious diseases, autoimmune diseases, and cancer; genetically modified cells, genome editing reagents and biological preparations, namely, viral vectors, all for the treatment of diseases, namely, genetic diseases, diseases of the immune system, infectious diseases, autoimmune diseases, and cancer
42 Pharmaceutical research and development
The mark consists of the stylized design of a number "7" comprised of a dark elongated upper triangle and a light elongated lower triangle. The elongated upper triangle has a rounded point at its upper right, and its lower side is curved inwardly where it interfaces with the lower elongated triangle, which has a rounded point at its upper right.
SEVEN
Color is not claimed as a feature of the mark.
Jan 4, 2024
Sou Extension 2 Granted
Jan 4, 2024
Sou Extension 2 Filed
Jan 4, 2024
Sou Teas Extension Received
Jul 14, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 12, 2023
Sou Extension 1 Granted
Jul 12, 2023
Sou Extension 1 Filed
Jul 12, 2023
Sou Teas Extension Received
Jan 24, 2023
Noa E-Mailed - Sou Required From Applicant
Nov 29, 2022
Official Gazette Publication Confirmation E-Mailed
Nov 29, 2022
Published For Opposition
Nov 9, 2022
Notification Of Notice Of Publication E-Mailed
Oct 21, 2022
Approved For Pub - Principal Register
Oct 21, 2022
Examiner's Amendment Entered
Oct 21, 2022
Notification Of Examiners Amendment E-Mailed
Oct 21, 2022
Examiners Amendment E-Mailed
Oct 21, 2022
Examiners Amendment -Written
Oct 18, 2022
Assigned To Examiner
Jan 20, 2022
Notice Of Design Search Code E-Mailed
Jan 19, 2022
New Application Office Supplied Data Entered
Jan 14, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
